BCHE and Alzheimer disease: Finally, compounds 15 and 16, with the glycone l configuration, N9 purine ligation, and aromatic rings in their structure, showed metal chelation and some inhibition of the cholinesterases, both the animal and the human ones, at the tested concentration, becoming the first nucleoside-based molecules with potential to act as dual-target compounds against AD.